| Bioactivity | Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH (Compound 21b) is an EZH2 degrader and can be used for the research of lymphoma[1]. |
| Name | Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH |
| CAS | 2750350-39-9 |
| Formula | C34H43N3O7 |
| Molar Mass | 605.72 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Tu Y, et al. Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma. J Med Chem. 2021 Jul 22;64(14):10167-10184. |
Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH
CAS: 2750350-39-9 F: C34H43N3O7 W: 605.72
Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH (Compound 21b) is an EZH2 degrader and can be used for the research
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.